Physician
Rheumotolgy Associates
Rheumotolgy Associates was paid $323K by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 68% of everything it billed.
33Billing provider infoRHEUMOTOLGY ASSOCIATES
JACKSONVILLE, FL 32216
JACKSONVILLE, FL 32216
33aNPI1518272392assigned 08/17/2010
33bProvider typeRheumatology Physician
28Total paid$323K
24GClaims12,857
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Florida
Rank by total paid#10 of 55
Median peer was paid$43K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 917 | $27K | |
| 2019 | 2,860 | $59K | |
| 2020 | 2,209 | $65K | |
| 2021 | 1,865 | $42K | |
| 2022 | 1,943 | $31K | |
| 2023 | 1,967 | $61K | |
| 2024incomplete | 1,096 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68% | 8,073 | 6,788 | $219K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15% | 181 | 141 | $50K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 1,185 | 990 | $23K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.1% | 268 | 246 | $23K |
| 20610 | 1.6% | 253 | 185 | $5K | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 98 | 74 | $2K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 14 | 12 | $507.59 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 24 | 23 | $497.51 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 170 | 155 | $261.62 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 39 | 24 | $65.61 |
| 96401 | <1% | 327 | 131 | $48.62 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 275 | 246 | $0.00 |
14 more codes
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 652 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 215 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 651 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 31 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 54 | $0.00 |
| 4004F | 0% | 13 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 54 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 13 | $0.00 |
| 1123F | 0% | 37 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 29 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 55 | $0.00 |
| 1036F | 0% | 67 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 66 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZEB, SHAHID (PRESIDENT)